Dementia Discovery Fund

Cultivating Innovation in Dementia Research

SV won the mandate to manage the Dementia Discovery Fund in August 2015 against competition from more than fifteen other specialist healthcare venture capital firms.

Following the establishment of the World Dementia Council in 2014, the UK government’s Department of Health was asked to devise a framework with the goal of identifying new approaches more systematically and of generating disease modifying treatments for Dementia. This resulted in an initial partnership with some of the world’s largest pharmaceutical companies (GSK, J&J, Pfizer, Biogen, Lilly and Takeda) who joined the UK Department of Health and the charity Alzheimer’s Research UK in becoming cornerstone investors in the DDF. Astex has subsequently joined the group of investors in this innovative fund.

More information may be found on the Dementia Discovery Fund website –